Velpatasvir (Synonyms: GS-5816) |
| Katalog-Nr.GC19372 |
Velpatasvir (VEL, GS-5816) ist ein neuartiger pangenotypischer Hepatitis-C-Virus (HCV)-Nichtstrukturprotein-5A-(NS5A)-Inhibitor mit AktivitÄt gegen HCV-Replikons vom Genotyp 1 (GT1) bis GT6. Velpatasvir ist auch ein SARS-CoV 3CLpro-Inhibitor mit einem IC50 von 2,16 μM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1377049-84-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons.target: NS5A
References:
[1]. Lawitz EJ et al. Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A Protein. Antimicrob Agents Chemother. 2016 Aug 22;60(9):5368-78.
Average Rating: 5 (Based on Reviews and 5 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *